Once-a-month PrEP pill easily passes its first big test
A triumph for injectable PrEP, but a sobering result for oral PrEP
Antibody-based PrEP did not stop most types of HIV – but is still hailed as a ‘game changer’
European PrEP programmes face two big issues: how to get more people coming forward, and how to serve them if they do
Middle-aged people with HIV and no hepatitis co-infection have a twofold increase in the risk of liver fibrosis
Big fall in HIV cases in Scotland after roll-out of PrEP
Living with HIV associated with a fivefold increase in the risk of insomnia
Huge fall in new HIV infections after roll-out of PrEP in Scotland
Bacterial STI rates rose in the year before starting PrEP, but not during PrEP, Australian study finds
